Search Results - "Mitsuya H"

Molecular targets for AIDS therapy.

Authors: Mitsuya, H. Yarchoan, R.

Source: Science (pre-March 2025). 9/28/1990, Vol. 249 Issue 4976, p1533. 12p. 28 Diagrams, 1 Chart.

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.

Authors: Yarchoan, R. Mitsuya, H.

Source: Science (pre-March 2025). 7/28/1989, Vol. 245 Issue 4916, p412. 4p. 1 Diagram, 6 Graphs.

Clinical pharmacology of 3'-Azido-2',3'-dideoxythymidine (zidovudine) and related...

Authors: Yarchoan, R. Mitsuya, H.

Source: New England Journal of Medicine. 9/14/89, Vol. 321 Issue 11, p726. 13p. 10 Diagrams, 3 Charts.

This result is not displayed to guests.
Login for full access.

Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance.

Authors: Yin, P. D. Das, D. Mitsuya, H.

Source: Cellular & Molecular Life Sciences. Aug2006, Vol. 63 Issue 15, p1706-1724. 19p. 4 Color Photographs, 4 Diagrams, 1 Chart.

Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia.

Authors: Sonoki, T. Iwanaga, E. Mitsuya, H. et al.

Source: Leukemia (08876924). Nov2005, Vol. 19 Issue 11, p2009-2010. 2p. 1 Diagram.

PDK1 inhibition is a novel therapeutic target in multiple myeloma.

Authors: Fujiwara, S Kawano, Y Yuki, H et al.

Source: British Journal of Cancer. 1/15/2013, Vol. 108 Issue 1, p170-178. 9p. 1 Chart, 6 Graphs.

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

Authors: Ueno, S. Tatetsu, H. Hata, H. et al.

Source: Oncogene. 11/19/2009, Vol. 28 Issue 46, p4116-4125. 10p. 1 Black and White Photograph, 3 Charts, 4 Graphs.

Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment

Authors: Omata, N Murata, T Takamatsu, S et al.

Source: Bipolar Disorders. May2008, Vol. 10 Issue 3, p360-368. 9p. 1 Diagram, 4 Charts, 5 Graphs.

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).

Authors: Nanri, T. Matsuno, N. Kawakita, T. et al.

Source: Leukemia (08876924). Aug2005, Vol. 19 Issue 8, p1361-1366. 6p.

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype.

Authors: Matsuno, N. Osato, M. Yamashita, N. et al.

Source: Leukemia (08876924). Dec2003, Vol. 17 Issue 12, p2492-2499. 8p.

Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor.

Authors: Sonoki, T Matsuzaki, H Nagasaki, A et al.

Source: Leukemia (08876924). May99, Vol. 13 Issue 5, p713-718. 6p.

Expression of Bcl-2 family of proteins in fresh myeloma cells.

Authors: Harada, N. Hata, H. Yoshida, M. et al.

Source: Leukemia (08876924). Nov98, Vol. 12 Issue 11, p1817-1820. 4p.

Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation.

Authors: Nanri, T Matsuno, N Kawakita, T et al.

Source: Leukemia (08876924). Sep2005, Vol. 19 Issue 9, p1673-1675. 3p.

Transcriptional repression of the p15 gene predicts the clinical outcome of acute myeloblastic leukemia with intermediate and adverse cytogenetics.

Authors: Matsuno, N. Hoshino, K. Nanri, T. et al.

Source: Leukemia (08876924). Jun2004, Vol. 18 Issue 6, p1146-1148. 3p.

A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia.

Authors: Matsuno, N Nanri, T Kawakita, T et al.

Source: Leukemia (08876924). Mar2005, Vol. 19 Issue 3, p480-481. 2p.

Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Authors: Tomino, S. Fuhiwara, H. Kagimoto, T. et al.

Source: Clinical & Experimental Immunology. Jun1982, Vol. 48 Issue 3, p625-632. 8p.

Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients.

Authors: Harada, N Hata, H Matsuno, F et al.

Source: Leukemia (08876924). Sep99, Vol. 13 Issue 9, p1465-1466. 2p.

Effects of knee and hip flexion angle on region-specific and longitudinal compartmental muscle stiffness of the rectus femoris using shear wave elastography in male bodybuilders.

Authors: Mitsuya H Nakazato K Okada T

Source: European journal of applied physiology [Eur J Appl Physiol] 2025 Oct; Vol. 125 (10), pp. 2793-2804. Date of Electronic Publication: 2025 May 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 100954790 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-6327 (Electronic) Linking ISSN: 14396319 NLM ISO Abbreviation: Eur J Appl Physiol Subsets: MEDLINE

Electromyographic activity during bench press differs by attentional focus strategy and sport: a cross-sectional comparison of bodybuilding, powerlifting, and paralympic powerlifting.

Authors: Kosuge T Mitsuya H Hakkaku T et al.

Source: European journal of applied physiology [Eur J Appl Physiol] 2026 Jun; Vol. 126 (6), pp. 3139-3156. Date of Electronic Publication: 2026 Jan 24.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 100954790 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-6327 (Electronic) Linking ISSN: 14396319 NLM ISO Abbreviation: Eur J Appl Physiol Subsets: MEDLINE